Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Palbociclib in Metastatic Breast Cancer: Gene Polymorphism-based Study in Egyptian Patients.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06338644
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:52.278578+00:00
Published At
2024-03-29T00:00:00+00:00
Record Updated At
2024-03-29
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hormone-receptor-positive Breast Cancer", "Human Epidermal Growth Factor 2 Negative Carcinoma of Breast", "Metastatic Breast Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-03-29"
protocolSection.identificationModule.nctId
"NCT06338644"
protocolSection.identificationModule.officialTitle
"Palbociclib in Metastatic Breast Cancer: Gene Polymorphism-based Study in Egyptian Patients."
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Hormone-receptor-positive Breast Cancer (protocolSection.conditionsModule.conditions)
  • Human Epidermal Growth Factor 2 Negative Carcinoma of Breast (protocolSection.conditionsModule.conditions)
  • Metastatic Breast Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.